Lecicarbon

Sodium hydrogen carbonate, the active ingredient in Lecicarbon, is a buffering agent presented as a rectal formulation for rectal use. It helps neutralize acids and supplies bicarbonate and phosphate ions to maintain local pH balance.\n\nGNH India supplies Lecicarbon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lecicarbon, a rectal buffering preparation, is employed in clinical situations where local acid neutralization is desired.\n\n- Rectal acid neutralization: assists in correcting local pH disturbances in the rectal mucosa.\n- Adjunct in bowel preparation: contributes to a neutral environment before diagnostic or surgical procedures.\n- Support in systemic acid‑base management: provides bicarbonate and phosphate ions via the rectal route to aid overall acid‑base balance.

Common Side Effects:\n- Mild rectal irritation or burning sensation.\n- Abdominal discomfort or cramping.\n- Flatulence or bloating.\n- Nausea or mild vomiting.\n- Diarrhea or loose stools.\n- Transient electrolyte shifts (e.g., mild sodium increase).\n\nSerious or Rare Side Effects:\n- Severe electrolyte disturbances (hypernatremia, hyperphosphatemia).\n- Metabolic alkalosis.\n- Allergic reactions including rash, urticaria, or anaphylaxis.\n- Significant rectal bleeding.\n- Severe abdominal pain requiring medical evaluation.\n- Rare cases of renal impairment exacerbation.

Before using Lecicarbon, consider the following precautions.\n\n- Assess electrolyte status: monitor sodium and phosphate levels during therapy.\n- Avoid in severe renal impairment: risk of ion accumulation.\n- Use with caution in hypertension: sodium load may affect blood pressure.\n- Check for hypersensitivity: discontinue if allergic signs appear.\n- Pregnancy and lactation: limited data, evaluate risk‑benefit ratio.\n- Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lecicarbon may interact with other medications that affect electrolyte balance or acid‑base status.\n\nMajor Interactions (Avoid):\n- Concurrent oral sodium bicarbonate: risk of excessive alkalosis.\n- Intravenous phosphate solutions: additive phosphate load may cause hyperphosphatemia.\n- Potassium‑sparing diuretics: potential for electrolyte imbalance.\n\nModerate Interactions (Monitor Closely):\n- ACE inhibitors: monitor potassium levels.\n- Loop diuretics: watch for combined electrolyte shifts.\n- Other antacids or alkalinizing agents: additive effect on pH.